[Federal Register: June 3, 2004 (Volume 69, Number 107)]
[Notices]
[Page 31388-31391]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jn04-64]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
HIV Prevention With National Medical and Nursing Associations
Announcement Type: New.
Funding Opportunity Number: 04152.
Catalog of Federal Domestic Assistance Number: 93.118.
Key Dates: Letter of Intent Deadline: June 18, 2004.
Application Deadline: July 19, 2004.
Executive Summary: The Centers for Disease Control and Prevention
(CDC) announces the availability of fiscal year (FY) 2004 funds for a
cooperative agreement program with national medical and nursing
associations or societies to promote and assist with the implementation
of CDC's Initiative Advancing HIV Prevention: New Strategies for a
Changing Epidemic. The initiative aims to reduce barriers to early
diagnosis of HIV infection and increase access to quality medical care,
treatment, and ongoing prevention services. It emphasizes the use of
proven public health approaches to reducing the incidence and spread of
disease. As with other sexually transmitted diseases (STDs) or any
other public health problem, principles commonly applied to prevent
disease and its spread will be used, including appropriate routine
screening, identification of new cases, partner notification, and
increased availability of sustained treatment and prevention services
for those infected.
The initiative consists of four key strategies:
Make HIV testing a routine part of medical care.
Implement new models for diagnosing HIV infections outside
medical settings.
Prevent new infections by working with persons diagnosed
with HIV and their partners.
Further decrease perinatal HIV transmission.
I. Funding Opportunity Description
Authority: This program is authorized under sections 301(a) and
317(k)(2) of the Public Health Service Act, (42 U.S.C. 241(a) and
274b(k)(2)), as amended.
Purpose: The purpose of this program is to: (1) Develop and
disseminate provider educational and training materials to members; (2)
promote HIV testing as part of routine medical care; (3) promote the
incorporation of HIV prevention into the medical care of HIV-infected
persons; (4) foster the exchange of information, ideas and experiences
of health care providers on what works for preventing HIV; and (5)
stimulate involvement and participation of regional, state and local
chapters. This program addresses the ``Healthy People 2010'' focus area
of HIV.
Measurable outcomes of the program will be in alignment with one or
more of the following performance goals for the National Center for
HIV, STD and TB Prevention (NCHSTP): (1) Decrease the number of persons
at high risk for acquiring or transmitting HIV infection; (2) increase
the proportion of HIV-infected persons who know they are infected; (3)
increase the proportion of HIV-infected persons who are linked to
appropriate prevention, care, and treatment services; (4) strengthen
the capacity nationwide to monitor the epidemic, develop and implement
effective HIV prevention interventions and evaluate prevention
programs.
Activities: Awardee activities for this program are as follows:
a. Evaluate members for (1) knowledge, attitudes and perceptions
regarding the role of clinicians in HIV prevention; (2) adherence to
practice standards and federal or state clinical guidelines for the
prevention and treatment of HIV/AIDS and other STDs; (3) knowledge,
attitudes and barriers to the incorporation of the CDC/HRSA/NIH/IDSA
Recommendations to Incorporate HIV Prevention into the Medical Care of
Persons Living with HIV, into their clinical practice.
b. Assess capacity of regional, State and local chapters to support
the dissemination of educational and training materials.
c. Develop and disseminate provider training and educational
materials to promote HIV testing as part of routine medical care;
promote the incorporation of HIV prevention into the medical care of
persons living with HIV; and develop educational materials that
providers can use with their patients. Dissemination can be done
directly to members or through regional, State and local chapters.
d. Sponsor a variety of forums for presentation of information on
HIV testing as part of routine medical care; use of rapid testing in
medical settings, including acute care clinics and emergency
departments; and incorporation of HIV prevention into the medical care
of HIV-infected persons.
e. Conduct an evaluation of the intervention to measure changes in
attitudes, clinical behaviors and practices.
f. Collaborate with other funded national organizations and the
Division of HIV/AIDS Prevention, CDC, in the
[[Page 31389]]
development of training and educational materials for health care
providers and consumers.
g. Participate in two grantee meetings per year as defined by the
project officer.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC Activities for this program are as follows:
a. Facilitate and assist in the development of training materials
and curricula, administrative tools and policy manuals.
b. Participate in the evaluation design.
c. Provide information and technical expertise in the area of HIV
prevention, including prevention for persons living with HIV.
d. Work with each awardee to facilitate and support collaboration
among funded national organizations as well as CDC-funded HIV
prevention and surveillance programs.
e. Provide a synthesis of known best practices and interventions
regarding HIV risk assessment and testing, HIV prevention in medical
settings, rapid HIV testing, and prevention for HIV-infected persons.
f. Collaborate in the development of forums that focus on HIV
testing as part of routine medical care; use of rapid testing in
medical settings, including acute care clinics and emergency
departments; and incorporating HIV prevention into the medical care of
HIV-infected persons.
g. Collaborate with awardees on presentations and publications of
evaluation findings.
h. Conduct site visits to monitor progress of the programs.
II. Award Information
Type of Award: Cooperative agreement.
CDC involvement in this program is listed in the Activities Section
above.
Fiscal Year Funds: 2004.
Approximate Total Funding: $500,000.
Approximate Number of Awards: Three-Four.
Approximate Average Award: $100,000. (This amount is for the first
12-month budget period, and includes both direct and indirect costs.)
Floor of Award Range: $75,000.
Ceiling of Award Range: $175,000.
Anticipated Award Date: September 1, 2004.
Budget Period Length: 12 months.
Project Period Length: Two years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal government.
III. Eligibility Information
III.1. Eligible applicants
Applications may be submitted by public and private
nonprofit organizations.
This program is limited to national professional medical and
nursing associations or societies that have the capability to reach a
broad constituency to assure the dissemination of consistent HIV
prevention messages nationwide. These associations or societies must
represent practicing clinicians.
Funding preference will be given to national organizations with
prior experience in developing and disseminating provider educational
and training materials to promote prevention services.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding amount greater than the ceiling of the
award range, your application will be reviewed and, if awarded, only
partially funded.
Note: Title 2 of the United States Code, section 1611, states
that an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity use application form PHS
5161. Application forms and instructions are available on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Letter of Intent (LOI): Your LOI must be written in the following
format:
Maximum number of pages: one.
Font size: 12-point unreduced.
Single spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Written in plain language, avoid jargon.
Your LOI must contain the following information:
A summary of the project.
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 20.
If your narrative exceeds the page limit, only the first pages,
which are within the page limit, will be reviewed.
Font size: 12 point unreduced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Held together only by rubber bands or metal clips; not
bound in any other way.
Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed:
1. Abstract (not to exceed one page): An executive summary of your
program covered under this announcement.
2. Program Plan (Not to exceed 19 pages): In developing the
application under this announcement, please review the recipient
activities and, in particular, evaluation criteria and respond
concisely and completely. The program plan should address activities to
be conducted over the entire two-year budget period. Include proposed
methods and staffing plan for the project.
3. Budget: Submit an itemized budget for the entire two-year
project period, and supporting justification that is consistent with
your proposed program plan. Include travel costs for not more than two
staff members to attend two 2-day meetings in Atlanta each year.
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information can include:
Organizational chart, resumes for proposed staff, a letter
of support from the board of directors, and letters of support from
other project partners or collaborators;
Samples of previous projects related to this proposal.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain
[[Page 31390]]
a DUNS number, access http://www.dunandbradstreet.com or call 1-866-
705-5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
If your application form does not have a
DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter. Additional requirements that may require you
to submit additional documentation with your application are listed in
section ``VI.2. Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
LOI Deadline Date: June 18, 2004.
CDC requests that you send a LOI if you intend to apply for this
program. Although the LOI is not required, not binding, and does not
enter into the review of your subsequent application, the LOI will be
used to gauge the level of interest in this program, and to allow CDC
to plan the application review.
Application Deadline Date: July 19, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. eastern time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that your application did not meet the
submission requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.
IV.4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds from this cooperative agreement should not be used
for major purchase of equipment or construction. Requests for equipment
such as computers and Liquid Crystal Display (LCD) Projectors for
training require detailed justification.
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement should be less than 12
months of age.
Awards will not allow reimbursement of pre-award costs.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6. Other Submission Requirements
LOI Submission Address: Submit your LOI by express mail, delivery
service, fax, or e-mail to: Raul A. Romaguera, DMD, MPH, Associate
Director for Prevention in Care, Division of HIV/AIDS Prevention, CDC,
1600 Clifton Road, NE.--MS D-21, Atlanta, GA 30333. Telephone: (404)
639-2004, fax (404) 639-0897, e-mail: RRomaguera@cdc.gov.
Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:
Technical Information Management-PA 04152, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
V.1. Criteria
You are required to provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
1. Scope of Plan (30 points): The plan delineates your steps to
implement and evaluate your program. It must be written for your entire
two-year project period and include a succinct statement of the intent,
desired outcome(s) of the project and clearly stated and measurable
outcome objectives to be achieved by the project. These objectives must
be quantifiable in terms of outputs and time frame for achievement. The
statement of intent and outcome objectives should address the purpose
of the cooperative agreement, which is to: (1) Develop and disseminate
provider educational and training materials to members; (2) promote HIV
testing as part of routine medical care; (3) promote the incorporation
of HIV prevention into the medical care of HIV-infected persons; (4)
foster the exchange of information, ideas and experiences of health
care providers on what works for preventing HIV; (5) stimulate
involvement and participation of regional, state and local chapters.
2. Methods (30 points): Clear statement of approach and activities
required to achieve the stated HIV prevention outcome objectives. The
relationship between activities and objectives must be explicitly
demonstrated. Description of activities must include a delineation of
resources required, identification of the personnel who will perform
the work and a management plan with description of the systems and
procedures which will be used to manage the progress, budget and
operations of the project.
3. Personnel and Staffing (25 points): The qualifications and
experience of key personnel, other professional staff and support staff
available to carry out HIV prevention activities.
4. Evaluation (15 points): Detailed plans for evaluating the degree
to which the program achieves the purpose of the cooperative agreement
(as listed in the purpose section, and above in the description of the
scope of plan). Measures must be objective and quantitative and must
measure the intended outcome.
5. Budget (reviewed, but not scored): There is an upper limit of
$175,000. An application submitted with a budget over $175,000, will be
reviewed and, if awarded, only partially funded. The budget will be
reviewed to determine the extent to which it is reasonable, clearly
justified, consistent with the intended use of the funds, and
[[Page 31391]]
allowable. All budget categories should be itemized.
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff and for responsiveness by the NCHSTP.
Incomplete applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above.
In addition, the following factors may affect the funding decision:
This program is limited to national professional medical and
nursing associations or societies that have the capability to reach a
broad constituency to assure the dissemination of consistent HIV
prevention messages nationwide. These associations or societies must
represent practicing clinicians.
Funding preference will be given to national organizations with
prior experience in developing and disseminating provider educational
and training materials to promote prevention services.
V.3. Anticipated Announcement and Award Dates
September 1, 2004.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR part 74 and part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-4 HIV/AIDS Confidentiality Provisions.
AR-5 HIV Program Review Panel Requirements.
AR-9 Paperwork Reduction Act Requirements.
AR-10 Smoke-Free Workplace Requirements.
AR-11 Healthy People 2010.
AR-12 Lobbying Restrictions.
AR-14 Accounting System Requirements.
AR-15 Proof of Non-Profit Status.
AR-16 Security Clearance Requirement.
AR-20 Conference Support.
AR-24 Health Insurance Portability and Accountability Act
Requirements.
AR-25 Release and Sharing of Data.
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, no less than 90 days before the end of
the budget period. The progress report will serve as your non-competing
continuation application, and must contain the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Additional Requested Information.
f. Measures of Effectiveness.
2. Financial status report and annual progress report, no more than
90 days after the end of the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
For general questions about this announcement, contact: Technical
Information Management Section, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341. Telephone: 770-488-2700.
For program technical assistance, contact: Raul A. Romaguera, DMD,
MPH, Associate Director for Prevention in Care, Division of HIV/AIDS
Prevention, CDC, 1600 Clifton Road, NE.--MS D-21, Atlanta, GA 30333.
Telephone: 404-639-2004, fax: 404-639-0897, e-mail: RRomaguera@cdc.gov.
For financial, grants management, or budget assistance, contact:
Kang Lee, Grants Management Specialist, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341. Telephone: 770-488-
2733, e-mail: kil8@cdc.gov.
VIII. Other Information
Additional information regarding Advancing HIV Prevention: New
Strategies for a Changing Epidemic is available at the following
Internet address Web site: http://www.cdc.gov/nchstp/od/nchstp.html.
Dated: May 27, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-12569 Filed 6-2-04; 8:45 am]
BILLING CODE 4163-18-P